Informed consent and risk management in dermatology: to what extent do dermatologists disclose alternate diagnostic and treatment options to their patients?
Shriner
D L
DL
University of Texas Medical Branch, Galveston.
Wagner
R F
RF
Weedn
V W
VW
Winslade
W J
WJ
Aragona
J M
JM
D000328:Adult; D002280:Basal Cell Carcinoma / Q000532:radiotherapy / Q000601:surgery; D003880:Dermatology / Q000331:legislation & jurisprudence* / Q000592:standards / Q000706:statistics & numerical data; D030881:Disclosure; D004416:Dysplastic Nevus Syndrome / Q000235:genetics / Q000601:surgery / Q000628:therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D008297:Male; D008545:Melanoma / Q000601:surgery / Q000628:therapy; D026706:Paternalism; D010358:Patient Participation / Q000331:legislation & jurisprudence; D026684:Personal Autonomy; D018570:Risk Assessment; D012307:Risk Factors; D012308:Risk Management / Q000331:legislation & jurisprudence*; D013341:Sturge-Weber Syndrome / Q000532:radiotherapy; D011795:Surveys and Questionnaires; D014342:Truth Disclosure; D014481:United States